Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Aggregate statistics from Disclosed's verified COA corpus. All numbers are computed directly from lab-uploaded Certificates of Analysis — no editorial claims, no estimates.
COAs
1
Labs
1
Vendors tested
1
Avg purity
98.9%
±0.0%
Endotoxin tested
0%
of all COAs tested
Sterility tested
0%
of all COAs tested
Methodology:Purity averages exclude values outside [50%, 100%] to filter unit misreads. "Vendors tested" counts distinct vendor IDs across all in-scope, non-withdrawn, extracted COAs. Endotoxin/sterility coverage denominators are all in-scope COAs (not filtered to parenteral form).
Data updates hourly. All figures are computed from lab-uploaded COAs; Disclosed does not perform independent testing.
Based on 1 Certificate of Analysis in the Disclosed corpus, 4-Hydroxytamoxifen (Afimoxifene) has an average HPLC purity of 98.9% (±0.0% std dev). This figure spans 1 vendor tested across 1 independent lab. Purity is measured by high-performance liquid chromatography (HPLC); values outside 50–100% are excluded as unit misreads.
1 distinct testing lab has produced COAs for 4-Hydroxytamoxifen (Afimoxifene) in the Disclosed database, covering 1 total test across 1 vendor.
Disclosed Labs